CTIS.eu › Cities › Greece › Alexandroupoli
Alexandroupoli
Greece
90 total trials
38 recruiting
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
2023-508875-35-00
5
2025-09-01
Heart condition
2024-520154-38-00
5
2025-07-29
Acute Myeloid Luekemia
2024-517247-31-00
5
2025-07-07
Newly Diagnosed Higher Risk Myelodysplastic Syndrome
2024-519219-32-00
5
2025-06-23
Heart Failure With Reduced Ejection Fraction
2023-506460-14-00
5
2025-05-07
Chronic kidney disease (CKD) and hypertension.
2024-516030-35-00
5
2025-04-30
Multiple myeloma
2024-515566-13-00
5
2025-03-19
Diffuse Large B-Cell Lymphoma (DLBCL)
2023-508813-18-00
4
2024-12-18
Refractory Focal Onset Epilepsy
2023-508581-15-00
5
2024-10-08
Heart condition
2023-508811-21-00
10
2024-09-25
Refractory Focal Onset Epilepsy
2023-508162-15-00
5
2024-07-12
Chronic HF and comorbid impairment of kidney function who had a recent
2022-501697-19-01
5
2024-06-18
Small Lymphocytic Lymphoma (SLL) / Untreated Chronic Lymphocytic Leuke
2023-507751-30-00
9
2024-05-27
relapsed or refractory multiple myeloma
2023-505221-14-00
4
2024-04-04
Multiple Myeloma
2023-507295-40-00
5
2024-02-12
Community-acquired pneumonia
2023-510384-36-00
5
2022-09-13
Newly Diagnosed Multiple Myeloma
2022-502646-27-00
10
2022-06-24
Relapsed or Refractory Diffuse Large B-Cell Lymphoma
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
2024-518263-35-00
4
2021-11-23
Primary plasma cell leukemia
2025-521096-31-00
5
2025-10-02
Chronic Hepatitis C Virus (HCV) Infection
2024-515255-38-00
4
2025-03-12
SEPSIS
2024-511933-36-00
4
2025-01-02
Diffuse cutaneous systemic sclerosis (dcSSc)
2024-512147-23-00
10
2024-11-21
Chronic Lymphocytic Leukemia
Showing 25–48 of 90 trials